摘要
目的评估支气管动脉栓塞术(bronchial artery embolization,BAE)联合手术治疗支气管扩张顽固性咯血的效果。方法收集2018年1月至2022年1月武汉金银潭医院诊治的168例支气管扩张顽固性咯血患者的临床资料。91例患者行肺叶切除术(对照组),71例患者行BAE联合肺叶切除术(观察组)。比较2组患者的疗效、术中出血量、手术操作时间、术后3 d引流量、住院时间、咯血复发率,并比较并发症情况。结果观察组患者临床疗效更高,且术中出血量、手术操作时间、住院时间、术后3 d引流量和复发率低于对照组(P<0.05)。两组并发症发生率差异无统计学意义(P>0.05)。结论BAE联合肺叶切除术可提高治疗效果,不会增加并发症风险。
Objective To evaluate the effectiveness of bronchial artery embolization(BAE)combined with surgical lobectomy in treating patients with refractory hemoptysis caused by bronchiectasis.Methods The clinical data of 168 patients with bronchiectasis and refractory hemoptysis,who were treated at the Wuhan Jinyintan Hospital of China from January 2018 to January 2022,were retrospectively analyzed.Of the 168 patients,91 underwent lobectomy(control group),and 71 underwent BAE combined with lobectomy(observation group).The therapeutic efficacy,intraoperative blood loss,surgical operation time,postoperative 3-day drainage volume,length of hospital stay,hemoptysis recurrence rate,and complications were compared between the two groups.Results In the observation group,the clinical efficacy was higher than that in the control group,while the intraoperative blood loss,operation time,length of hospital stay,postoperative 3-day drainage volume and recurrence rate were lower than those in the control group(all P<0.05).No statistically significant difference in the incidence of complications existed between the two groups(P>0.05).Conclusion In treating patients with refractory hemoptysis due to bronchiectasis,BAE combined with lobectomy can improve the therapeutic efficacy while not increasing the risk of complications.
作者
隋虎
樊艳青
谭刚华
程文涛
SUI Hu;FAN Yanqing;TAN Ganghua;CHENG Wentao(Department of Radiology,Affiliated Wuhan Jinyintan Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,Hubei Province 430023,China)
出处
《介入放射学杂志》
北大核心
2025年第7期752-755,共4页
Journal of Interventional Radiology
基金
湖北省教育厅科学研究计划青年项目(Q20221114)。
